Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Apogee Technology was a micro-electromechanical systems (MEMS) and nanotechnology company that transitioned into the life sciences sector to develop advanced drug delivery systems. The company's primary innovation was the Pyra-Derm platform, a proprietary micro-needle technology designed for the intradermal delivery of drugs and vaccines. This technology aimed to provide a painless, easy-to-administer alternative to traditional syringe injections while potentially enhancing the efficacy of biologics and vaccines. Despite its technological promise in the early 2000s, the company faced significant financial challenges and eventually ceased its primary operations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Apogee Technology.